Joseph E. Turk Jr. is President at NxStage Medical, Inc. (NXTM). They have made 11 open-market trades across 1 company since 2016, most recently 2018-05-21.
CIK 0001333170
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NXTM | 86,401 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2018-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NXTM | SELL | 2017-08-07 | 2017-08-08 | $29.64 | $711K | -0.3% | -4.9% | -9.3% |
| NXTM | SELL | 2017-08-03 | 2017-08-04 | $22.98 | $161K | -1.3% | -5.6% | -9.4% |
| NXTM | SELL | 2017-06-08 | 2017-06-12 | $23.59 | $53K | -2.2% | +4.7% | +18.2% |
| NXTM | SELL | 2017-02-17 | 2017-02-21 | $29.66 | $178K | -2.4% | -9.7% | -25.8% |
| NXTM | SELL | 2017-02-10 | 2017-02-13 | $28.59 | $71K | +3.1% | +0.3% | -21.6% |
| NXTM | SELL | 2017-02-02 | 2017-02-02 | $26.19 | $410K | +5.2% | +3.6% | +0.4% |
| NXTM | SELL | 2017-01-13 | 2017-01-17 | $28.00 | $210K | -3.1% | +6.8% | -5.6% |
| NXTM | SELL | 2016-11-28 | 2016-11-29 | $26.48 | $71K | -1.4% | +1.9% | +14.8% |
| NXTM | SELL | 2016-11-25 | 2016-11-29 | $26.01 | $316K | -1.4% | +1.9% | +14.8% |
| NXTM | SELL | 2016-11-16 | 2016-11-16 | $26.26 | $591K | -1.2% | -1.4% | +9.4% |
| NXTM | SELL | 2016-01-07 | 2016-01-08 | $20.78 | $77K | -4.6% | -15.2% | -27.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.